Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.70%
#2 Wibx Wibx +3.22%
#3 BOT BOT +2.51%
#4 TronBank TronBank +2.46%
#5 Cysic Cysic +2.29%
#6 Status Status +2.14%
#7 Starpower Starpower +2.06%
#8 Wiki Cat Wiki Cat +2.02%
#9 Tutorial Tutorial +1.90%
#10 The Bitcoin Bull The Bitcoin Bull +1.56%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Rapid Dose Therapeutics Corp. Rapid Dose Therapeutics Corp.

Rapid Dose Therapeutics Corp.

DOSE
Clasificación en acciones #32496
Rapid Dose Therapeutics Corp., headquartered in Burlington, Canada, is a life... Rapid Dose Therapeutics Corp., headquartered in Burlington, Canada, is a life sciences enterprise dedicated to developing advanced drug delivery technologies aimed at improving health results and individuals' quality of life. The company's flagship product is QuickStrip/PharmaStrip, an innovative oral, fast-dissolving film designed to swiftly introduce active compounds—such as pharmaceuticals, emulsified oils, and over-the-counter medicines—directly into the bloodstream. They offer specific QuickStrip variants like QuickStrip energy for caffeine delivery, QuickStrip B12 for vitamin B12 supplementation, and QuickStrip sleep for melatonin. Beyond its proprietary products, the firm also delivers comprehensive services encompassing product innovation, manufacturing, and consultation to industries including nutraceuticals, cannabis healthcare, and pharmaceutical production. Rapid Dose Therapeutics maintains a significant research collaboration with McMaster University, focusing on crafting enhanced biopolymer compositions for oral dissolvable thin films and investigating an orally administered vaccine candidate for COVID-19.
Precio por acción
$0.07339369
Última sincronización: 2026-08-17
Capitalización bursátil
$9.92M
Cambio (1 día)
-4.76%
Cambio (1 año)
-48.06%
País
CA
Comercio Rapid Dose Therapeutics Corp. (DOSE)

Categoría

Healthcare
Ganancias de Rapid Dose Therapeutics Corp. (DOSE)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Rapid Dose Therapeutics Corp., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Rapid Dose Therapeutics Corp. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE